Eye Injection Cost: How Much You’ll Pay in Australia

For many Australians living with conditions such as wet age-related macular degeneration or diabetic eye disease, regular eye injections are not just another appointment—they’re a lifeline for maintaining vision and independence. Yet, the reality of ongoing treatment can bring a new concern: how much will each injection cost, and what will this mean over the course of a year, or even a lifetime? With out-of-pocket expenses for intravitreal injections varying widely—from as little as $75 in Tasmania to more than $330 in the ACT—navigating the true cost can feel overwhelming, especially when frequent visits become a part of routine life.

Understanding the breakdown of these costs is essential for patients and families planning their care. It’s not just the medication itself; consultation fees, diagnostic scans, and the fine print around Medicare and PBS rebates all play a role. For those on a fixed income or managing other health expenses, these charges add up quickly, sometimes forcing difficult choices about treatment adherence and quality of life.

This article aims to cut through the confusion. We’ll unpack each element that contributes to the cost of eye injections in Australia, spotlight the government supports available, and share practical strategies for reducing your expenses—whether through concession cards, bulk-billing clinics, or specialist assistance programs. Throughout, we’ll also highlight the benefits of transparent, patient-focused providers like Bright Sight Eye Specialists, who are committed to making high-quality eye care accessible and affordable. If you’re seeking clarity about what to expect and how to plan, you’re in the right place.

1. Understanding Intravitreal Eye Injections: Purpose and Procedure

intravitreal eye injections have become the cornerstone of treatment for a range of retinal conditions, delivering medication directly into the eye’s vitreous cavity. By placing drugs at the precise site of disease activity, these injections help slow or even reverse the progression of conditions like wet age-related macular degeneration and diabetic macular oedema. Although the idea of an injection into the eye may sound daunting, the procedure is quick, generally well tolerated, and often performed in an outpatient setting with minimal discomfort.

At Bright Sight Eye Specialists, we emphasise patient education and comfort throughout this process. A typical visit will include a thorough assessment—reviewing your vision history, examining the retina with specialised imaging, and discussing the treatment plan—before proceeding to the injection itself. Understanding how these injections work and why they’re needed can ease concerns and empower you to take an active role in your eye health.

What are Intravitreal Injections?

Intravitreal injections involve introducing medication directly into the vitreous humour, the clear gel that fills the back of the eye. This targeted delivery allows drugs to reach the retina at therapeutic concentrations without systemic side effects.

Most commonly, anti-VEGF (vascular endothelial growth factor) agents are used. VEGF is a protein that promotes the growth of abnormal blood vessels, which leak fluid and impair vision. By blocking VEGF, drugs such as ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) reduce fluid leakage and stabilise the retinal structure. Steroid injections may also be employed to reduce inflammation in selected cases, though anti-VEGF therapy remains the first-line approach for many retinal diseases.

Conditions Treated with Eye Injections

Intravitreal injections are prescribed for several sight-threatening conditions, including:

• Wet age-related macular degeneration (wet AMD)
• Diabetic macular oedema (DMO)
• Retinal vein occlusion (RVO)
• Epiretinal membrane (macular pucker)
• Macular hole

In 2023, over 108,000 Australians received intravitreal injections for treatable macular disease, highlighting how common and essential this therapy has become. Whether managing vision loss from diabetic retinopathy or tackling the rapid fluid leakage of wet AMD, these injections play a vital role in preserving sight.

Frequency and Duration of Treatment

Treatment regimens vary according to disease severity and drug choice, but most patients start with monthly injections. Over time, if the retina responds well, intervals may be extended to six to eight weeks—or even longer—with some of the newer medications. Despite this flexibility, many individuals remain on therapy for years, as stopping treatment can lead to a resurgence of fluid and vision decline.

Your ophthalmologist will tailor the schedule to your individual response, monitoring changes with optical coherence tomography (OCT) scans and clinical examinations. This long-term commitment underscores the importance of understanding not just the medical benefits of intravitreal injections, but also the practical and financial considerations of ongoing care.

2. Breakdown of Direct Costs per Injection

When you arrive for an eye injection, several charges contribute to your out-of-pocket expense. Broadly, these fall into three categories: the medication itself, the procedural fee charged by your ophthalmologist, and any diagnostic or ancillary services required before or after the injection. Understanding each component will help you anticipate costs and plan your budget.

Medication Fees and PBS Subsidies

Anti-VEGF drugs form the bulk of the medication cost. Fortunately, most injections are subsidised under the Pharmaceutical Benefits Scheme (PBS). Under current arrangements, each prescription attracts a co-payment of:

• $31.60 for general patients
• $7.70 for concession-card holders

By contrast, the full Dispensed Price for Maximum Quantity (including the PBS subsidy) ranges from around $786.36 for ranibizumab (Lucentis) to $890.64 for aflibercept (Eylea). To check the full PBS listing and eligibility criteria for these medications, visit the PBS page for anti-VEGF injections.

Procedural Costs and MBS Rebates

Delivering the injection involves professional fees, which are governed by the Medicare Benefits Schedule (MBS). The relevant item numbers are:

• 42738 – Intravitreal injection
• 42739 – Intravitreal injection with sedation or additional anaesthetic

The current schedule fee for each injection is $342.65. If the procedure is performed in rooms, Medicare will rebate 85% (approximately $291.30); in a private hospital or day-surgery setting, the rebate is 75% (about $257.00). The difference—roughly $51.35 in rooms—represents the standard “gap” you might pay. Should your ophthalmologist charge above the MBS fee, your out-of-pocket amount will increase. For a full explanation of MBS rebates and safety-net thresholds, see the MDFA’s guide to Medicare benefits.

Diagnostic Scans and Additional Service Fees

Before each injection, your retina will often be imaged with optical coherence tomography (OCT) to guide treatment. An OCT scan typically costs around $95 (or $78 concession), although Medicare only subsidises one scan per year under certain PBS criteria. Outside of that, you’ll cover the full cost.

Other services that can add to your bill include:

• Specialist consultation and follow-up visits
• Anaesthetic eye drops and dilating drops
• Any further imaging or visual field tests

These ancillary fees vary by clinic. It’s a good idea to request a detailed estimate—including scan and consultation charges—before committing to treatment, so you can avoid unwelcome surprises on your bill.

3. How Medicare and PBS Reduce Your Out-of-Pocket Expenses

While the price tag on eye injections can feel steep, both the Pharmaceutical Benefits Scheme (PBS) and Medicare play a vital role in lightening the load. Here’s how these two pillars of Australian healthcare work together to cut your direct costs on intravitreal injections.

Key PBS Listings for Eye Injection Medications

Under the PBS, the most commonly used anti-VEGF and steroid injections are subsidised, meaning you pay only a fraction of the full drug cost. Medications covered include:

• Ranibizumab (Lucentis) and aflibercept (Eylea) for wet age-related macular degeneration, diabetic macular oedema and retinal vein occlusion.
• Other approved indications as specified under the PBS.

To qualify, you need a valid prescription from your ophthalmologist and to meet clinical criteria such as diagnosis and prior treatment history. Once approved, each script attracts a co-payment of:

• $31.60 for general patients
• $7.70 for concession-card holders

This subsidy transforms a drug priced upwards of $700 into a much more manageable expense. For full details on listings and eligibility, check the PBS entry for anti-VEGF medications.

Navigating the PBS Safety Net

If you’re undergoing frequent injections, you’ll quickly accumulate co-payments. That’s where the PBS Safety Net comes in. After you’ve spent:

• $1,694 in a calendar year as a general patient, or
• $277.20 as a concession-card holder

on PBS-listed medications, your scripts for the remainder of the year drop to just $7.70 (general) or free (concession). Tracking your scripts can be as simple as keeping your receipts organised or using your MyGov PBS safety-net statement. Once you hit the threshold, you’ll enjoy a significant cut in your ongoing injection costs.

Making the Most of Medicare Rebates

On top of PBS subsidies, Medicare also offers rebates against the procedural fees set out in the Medicare Benefits Schedule (MBS). Key points include:

• Standard rebate: 85% of the MBS fee (item 42738) when injections occur in consulting rooms, and 75% (item 42739) if sedation or a hospital setting is involved.
• Medicare Safety Net: Once you reach the threshold of $576 in out-of-pocket MBS costs for the year, rebates increase to 100% of the MBS schedule fee, further trimming your gap.

Be aware that if you have both eyes treated on the same day, the rebate for the second injection drops to 50%. Saving every claim slip and reviewing your Medicare statements regularly will help you maximise rebate benefits and keep better track of your eye care spend. For more on these rebates and thresholds, the Macular Disease Foundation’s Medicare guide provides a handy breakdown.

By combining PBS subsidies with Medicare rebates, you can substantially reduce the financial strain of ongoing eye injections and focus on what matters most—preserving your vision.

4. Regional Variations in Injection Costs Across Australia

While the national median out-of-pocket cost for intravitreal injections sits at around $219, patients in different states and territories can experience markedly different expenses. In Tasmania, the median charge is as low as $75 per injection, whereas in the Australian Capital Territory it can climb to $339. This three- to four-fold difference underscores the importance of shopping around and factoring location into your treatment plan.

These figures illustrate only the extremes and the national average. In most other regions, median costs tend to cluster around the national figure, though local practice fees and overheads can nudge prices up or down by a few dozen dollars.

Factors Influencing Cost Disparities

Several elements drive the variation in injection costs from one jurisdiction to another:

• Clinic overheads: Rent, staffing and equipment costs are typically higher in metropolitan areas and capital cities, pushing fees up.
• Surgeon fees: Ophthalmologists in high-demand locations may charge above the MBS schedule fee, increasing the gap.
• Volume of procedures: Larger clinics delivering hundreds of injections monthly can often offer more competitive pricing than smaller practices.
• Regional travel: Patients in rural or remote areas may incur additional expenses for transport, accommodation and time off work, adding to the effective cost of care.

Understanding these drivers can help you anticipate where you might find savings—or where you’ll need to budget a bit more generously.

Implications for Patients and Referrers

For patients, knowing the typical fees in your region empowers you to:

• Request a ballpark estimate from several local clinics before booking your first injection.
• Factor in travel or accommodation costs if you live outside a major centre.
• Check whether state or territory health schemes offer additional concessions for private treatments.

Referrers—optometrists and GPs—can support their patients by:

• Including local cost estimates in referral letters or patient information packs.
• Advising on clinics known for competitive fees or bulk-billing options.
• Encouraging early conversations about financial planning, especially for those requiring long-term therapy.

By recognising that location plays a significant role in injection costs, both patients and referrers can take proactive steps to minimise out-of-pocket expenses without compromising on the quality of care.

5. Private Health Insurance and Bulk Billing Options

While government rebates go a long way to reduce the cost of eye injections, many patients turn to private health insurance or seek bulk-billing clinics to further limit out-of-pocket expenses. Here’s what you need to know about both routes.

Impact of Private Health Insurance on Eye Injection Costs

Private health policies often cover hospital facility fees when injections are performed in a day-surgery or private hospital setting. However, they typically do not cover the ophthalmologist’s professional fee, so you may still face a gap for items 42738 and 42739. Depending on your level of cover, excesses and co-payments may apply.

One notable change on the horizon is the deferred reclassification of intravitreal injections under the Medicare Benefits Schedule (MBS). Originally scheduled for July 2025, this reclassification has been pushed back to July 2026. The shift could affect how private insurers calculate benefits for these procedures, potentially altering gap amounts or waiting periods. It’s wise to review your policy now—particularly if you’re considering treatment in a private facility—and confirm with your fund how reclassification might impact your cover.

Bulk-Billing Eye Injection Clinics

Bulk billing means the clinic bills Medicare directly, leaving you with no gap to pay beyond the MBS rebate. While less common for specialist injections than for general practice, a small network of dedicated clinics and ophthalmologists offer bulk-billed intravitreal injections, especially for concession-card holders.

To find a bulk-billing provider:

• Check state health-service directories or GP referral networks.
• Search for “bulk billing eye injections” online.
• Ask your optometrist for recommendations—local practitioners often know which clinics bulk-bill.

Bulk billing can be an excellent option for patients on a tight budget or pensioners who need frequent injections, removing the uncertainty of fluctuating gap fees.

Preparing for Upcoming Policy Changes

With the MBS reclassification now deferred to July 2026, you have time to plan:

• Review your private health cover: Contact your insurer about any waiting periods, excesses or co-payments that could apply once the new item classifications take effect.
• Lock in existing benefits: If you’re thinking of changing funds or upgrading cover, do so before any waiting-period reset might delay your access to injection benefits.
• Stay informed: Watch for announcements from Medicare, private health funds and patient advocacy groups so you can adapt quickly to new billing rules.

By understanding how private insurance and bulk billing work—and by staying ahead of policy shifts—you’ll be better placed to manage your eye injection cost without compromising on the quality of care.

6. Total Annual Cost of Ongoing Eye Injection Therapy

Understanding how per-injection fees translate into a yearly bill is essential for anyone embarking on long-term intravitreal therapy. Below, we break down typical scenarios so you can better anticipate your annual expenditure.

Calculating Annual Expenses Based on Treatment Frequency

Most patients begin with monthly injections and, once stable, may extend to bimonthly or quarterly visits. Assuming a median out-of-pocket cost of $219 per injection and an average of nine treatments per year, the calculation is straightforward:

9 injections × $219 per injection = $1,971 annually

In regions with lower fees—such as Tasmania at around $75 per injection—the annual cost can be as little as:

9 injections × $75 per injection = $675 annually

Conversely, in higher-cost areas like the ACT (median $339), the yearly total jumps to:

9 injections × $339 per injection = $3,051 annually

Adjust these figures according to your treatment plan. If your ophthalmologist transitions you to six injections per year, simply replace “9” with “6” in the formula above to estimate your own annual spend.

Financial Burden for Pensioners and Low-Income Patients

A 2025 survey by the Macular Disease Foundation Australia (MDFA) found that patients receiving regular intravitreal injections face a median annual out-of-pocket cost of $3,621. For many pensioners, this represents about 12% of their yearly government pension, while one in ten pay more than $6,000—a hefty 20% of annual pension income.

Such expenses can strain household budgets, forcing some to choose between essential living costs and vision-saving treatment. Recognising this burden is the first step towards seeking concessions, bulk-billing options or patient support programs that may ease the load.

Treatment Adherence and Discontinuation Rates

Sadly, cost concerns contribute to treatment drop-off. Studies show up to 50% of patients discontinue therapy within five years—often citing financial pressure as the primary reason. Yet interrupted or halted injections can lead to a resurgence of fluid in the retina and irreversible vision loss.

By forecasting your annual injection costs and exploring every avenue for subsidy or rebate, you improve the chances of maintaining a consistent treatment schedule—and preserving sight—for the long term.

7. Ways to Lower Your Eye Injection Costs

Even with PBS and Medicare subsidies, the ongoing expense of eye injections can add up quickly. Fortunately, several strategies can help reduce your out-of-pocket costs. From leveraging government concessions to tapping into patient-assistance programmes, and by engaging openly with your ophthalmologist, you can ease the financial burden of long-term treatment.

Concession Cards and Veteran Support

If you hold a Pensioner Concession, Health Care or Department of Veterans’ Affairs (DVA) card, you’re entitled to lower fees on both medications and services:

• Reduced PBS co-payments: Concession-card holders pay just $7.70 per script for PBS-listed anti-VEGF drugs, compared with $31.60 for general patients.
• Discounted scan fees: Optical coherence tomography (OCT) scans often cost around $95, but concession holders can access scans for approximately $78.
• State health concessions: Many states offer additional rebates or transport assistance for concession-card holders undergoing private treatments.

To make the most of these benefits, carry your concession card to every appointment and confirm with each provider before booking that you’ll be charged the concession rate.

Accessing Patient Assistance Programs

Drug manufacturers and non-profit organisations frequently offer financial support to patients who struggle with treatment costs:

• Pharmaceutical company schemes: Genentech (Lucentis, Vabysmo), Bayer/Regeneron (Eylea) and Novartis (Beovu) provide income-based copay assistance or free medicine for eligible uninsured or underinsured patients.
• Charity grants and travel subsidies: The Macular Disease Foundation Australia (MDFA) offers guidance lines, local support networks and occasional travel grants for regional patients. Other charities, such as the Patient Access Network (PAN) Foundation, may help cover related costs.
• How to apply: Ask your ophthalmologist or clinic coordinator for application forms, income thresholds and turnaround times. Many programmes are designed for quick enrolment, ensuring minimal delay before your next injection.

Discussing Fees with Your Ophthalmologist

Transparency is key when managing healthcare expenses. Before committing to injections:

1. Request a written fee estimate
   Ask for a breakdown of charges—including MBS item numbers, scan fees, anaesthetic costs and any anticipated gap fees—so you have a clear picture of your total outlay.

2. Explore payment plans
   Some clinics may offer instalment options or sliding-scale fees based on financial hardship. Don’t hesitate to discuss your situation; most providers prefer to keep you on treatment rather than see you discontinue care because of cost.

3. Compare providers
   If you face high gap fees, consider obtaining quotes from multiple ophthalmologists. Practices like Bright Sight Eye Specialists are committed to transparent, patient-centred pricing and can provide detailed cost guides upfront.

By combining concession-card benefits, patient-assistance programmes and open dialogue with your ophthalmologist, you can significantly lower the cost of essential eye injections. For tailored advice and transparent pricing details, visit Bright Sight Eye Specialists.

8. Tips for Choosing an Affordable Eye Specialist

Finding the right ophthalmologist involves more than just expertise—it’s also about securing fair, transparent pricing that fits your budget. By doing some homework up front, you can reduce unexpected bills and focus on what matters: effective, ongoing treatment.

Comparing Provider Fees and Gap Estimates

Before making an appointment, ring around a few clinics to get a sense of their fee structures. Ask specifically for estimated out-of-pocket costs associated with MBS item numbers 42738 (standard intravitreal injection) and 42739 (injection with sedation or extra anaesthetic). You might also check:

• Whether anaesthetic drops or sedation incur extra fees
• The cost of required diagnostic scans (OCT, visual field tests)
• Charges for bilateral injections on the same day
• Any additional consultation or follow-up visit fees

Gathering these ballpark figures will help you compare providers on a like-for-like basis and avoid surprises when the bill arrives.

Transparency in Pricing and “No Gap” Options

A “no gap” arrangement means the specialist bills only up to the Medicare schedule fee, leaving you with nothing extra to pay beyond the rebate. Not all clinics offer this, so it’s worth asking if they provide no-gap injections or capped-fee packages. Practices that prioritise transparent pricing—like Bright Sight Eye Specialists—can furnish detailed cost guides in advance, outlining exactly what you’ll pay for each component of your care.

Patient Reviews and Recommendations

Word of mouth remains one of the best ways to gauge both the quality of care and the fairness of billing. Look for patient testimonials on Google, health-review sites or local support-group forums. Ask your optometrist or GP for recommendations—clinic staff often know which ophthalmologists deliver reliable treatment without hefty out-of-pocket charges. Hearing about others’ experiences can steer you towards specialists who combine clinical excellence with honest, upfront pricing.

9. Financial Aid and Support for Vision-Saving Treatments

Even with PBS subsidies and Medicare rebates, the cumulative cost of long-term eye injections can be daunting. Fortunately, a combination of advocacy initiatives and support programmes exist to help bridge the financial gap. Below, we outline key resources and actions to ease the burden of vision-saving treatments.

Macular Disease Foundation Australia Initiatives

The Macular Disease Foundation Australia (MDFA) has been at the forefront of calls for bulk-billing incentives to ensure that vulnerable patients can continue life-preserving eye injections without prohibitive out-of-pocket costs. In its Federal Election Agenda, Fight for Sight, MDFA proposed a Neovascular AMD Treatment Incentive Program aimed at encouraging ophthalmologists to bulk‐bill pensioners receiving injections for neovascular age-related macular degeneration.

According to MDFA and University of New South Wales research, such a program would cost the government an estimated $11.1 million per year but could save around $140 million in broader healthcare and social support expenses—freeing up vital pension income for everyday living costs.

Advocacy for Bulk Billing Incentives

Policy change is driven by engaged communities. You can support MDFA’s bulk-billing campaign by:

• Signing their online petitions or emailing your federal representative to express support for sight-saving bulk billing.
• Sharing your story of treatment costs on social media using MDFA’s campaign hashtag.
• Subscribing to MDFA’s newsletter and forwarding it to friends or health professionals who can help amplify the message.

By adding your voice, you help push bulk billing for intravitreal injections higher on the political agenda—and closer to reality.

Other Non-Profit Assistance Programs

Beyond MDFA, a range of not-for-profit organisations and community groups offer practical help:

• MDFA Support Services
  The MDFA runs a national helpline (1800 111 709) and an online hub for peer support groups, travel grants and low-vision training. Learn more at the Support Services Overview.

• State and Territory Vision Associations
  Each jurisdiction has its own vision impairment organisation—often providing transport subsidies, equipment grants and orientation training. A quick web search for “low vision support [your state]” will identify local contacts.

• National Disability Insurance Scheme (NDIS)
  Eligible participants can apply for funding to purchase low-vision aids, assistive technology and mobility training. Visit the NDIS website or contact your local NDIA office to discuss support packages.

These programmes can reduce ancillary costs—such as specialist travel, magnifiers and vision rehabilitation—that often accompany intravitreal injection therapy. Exploring every avenue of financial aid ensures you stay on track with treatment and maintain your quality of life.

10. What to Expect When You Go for Your First Injection

Navigating your first intravitreal injection can be less daunting when you know what to expect. This section walks you through the pre-injection consultation, the steps on the day of treatment, and the post-injection care routine. Armed with this information, you can arrive prepared and confident, ready to take the first step in preserving your vision.

Pre-Injection Consultation and Pricing Discussion

Your initial consultation will set the foundation for successful treatment. You’ll meet with your ophthalmologist to review your medical and vision history, discuss symptoms, and answer any questions. Expect an examination of your retina, often using an optical coherence tomography (OCT) scan to map fluid or swelling. Once the clinical picture is clear, the doctor will outline your treatment plan—how many injections, likely intervals and potential outcomes.

Importantly, this is the opportunity to clarify costs. Ask for a detailed fee estimate covering:

• MBS item numbers (42738 and 42739)
• Medication co-payments under the PBS
• Charges for scans, anaesthetic drops and consultations
• Any anticipated gap fees, including sedation or bilateral injections

Bring your referral letter, concession or DVA card, and private health insurance details to streamline the process and ensure you receive all applicable rebates.

The Day of the Injection: Step-by-Step

On the day of your first injection, plan to arrive a little early to complete any paperwork. After check-in, a nurse or technician will prepare you by applying antiseptic to the eye area and administering numbing eye drops. Once your vision is suitably anaesthetised, the ophthalmologist will gently position a lid speculum to keep your eyelids open and deliver the medication with a fine needle into the vitreous cavity. The actual injection takes only seconds.

Afterward, you’ll spend a short time in the waiting area—usually 10 to 15 minutes—to monitor for any immediate reactions. If sedation or an additional anaesthetic is required, discuss any extra fees beforehand. If you have both eyes treated, confirm whether any additional gap fees apply for the second injection.

Post-Injection Care and Follow-Up Costs

Most patients experience mild redness or a gritty sensation for a few hours after the procedure. Your ophthalmologist will provide written aftercare instructions, which may include avoiding strenuous activity, not rubbing the eye, and using prescribed eye drops to reduce inflammation.

Follow-up visits and OCT scans are essential to measure your eye’s response. Each follow-up can incur consultation and imaging fees similar to your initial assessment. As treatment intervals evolve—moving from monthly to bi-monthly or longer—the associated costs will adjust accordingly. Be sure to schedule and budget for these appointments in advance, and review any changes in your Medicare or PBS entitlements to keep your out-of-pocket expenses in check.

By understanding each stage of your first injection, you can manage both your expectations and your budget, making the journey to better vision smoother and more predictable.

Practical Steps to Manage Eye Injection Expenses

Managing the cost of ongoing eye injections doesn’t have to feel like navigating a maze. By taking a few proactive steps—understanding your entitlements, comparing local providers and having open conversations about fees—you can keep your treatment affordable and your sight secure.

1. Review Your Medicare and PBS Entitlements
   • Check your MyGov account or Medicare statements to track the PBS Safety Net and Medicare Safety Net thresholds.
   • Note how many scripts or MBS claims you’ve made so far this year and forecast when you’ll hit the reduced co-payment levels.
   • Keep all receipts and rebate statements in one folder or digital file to simplify claims and ensure you don’t miss out on savings.

2. Compare Fees at Multiple Clinics
   • Call at least two or three ophthalmology practices in your area for ballpark quotes on injection item numbers (42738, 42739), scan fees and any ancillary charges.
   • Ask whether they offer “no gap” injections or capped-fee packages, especially if you hold a concession or DVA card.
   • Factor in travel time and costs—sometimes a slightly higher procedure fee in a nearby suburb can still work out cheaper when you avoid long trips.

3. Discuss Costs Transparently with Your Ophthalmologist
   • At your first consultation, request a written estimate covering all anticipated fees: medication, procedure, scans, anaesthetic and follow-up visits.
   • If you’re concerned about cash flow, ask about payment plans or sliding-scale fees designed for patients on fixed incomes.
   • Let your specialist know about any concession cards or private health cover you hold; many practices will automatically apply reduced rates.

4. Explore Concessions and Patient Assistance Programs
   • Ensure you use any eligible Pensioner Concession, Health Care or DVA card to lower PBS co-payments (down to $7.70 per script) and scan fees.
   • Investigate pharmaceutical company schemes (from Genentech, Bayer/Regeneron or Novartis) that offer copay assistance or free medication for uninsured or underinsured patients.
   • Contact the Macular Disease Foundation Australia for travel grants, peer support and guidance on other non-profit subsidies.

By following these practical steps, you’ll be well placed to control your out-of-pocket costs and maintain the treatment schedule that protects your vision. For a clear, patient-focused approach to pricing and care, head to Bright Sight Eye Specialists—where transparent fee guides and expert advice await at Bright Sight Eye Specialists.